Hims & hers data shows personalized glp-1 plans drive real weight loss, few side effects, and strong adherence to care

San francisco--(business wire)--hims & hers health, inc. (“hims & hers”, nyse: hims), the leading health and wellness platform, today released new data showing that its personalized, digital-first approach to weight loss is driving meaningful, sustainable results, laying the groundwork for lasting success. in a first-of-its-kind u.s. analysis of treatment plans, including compounded glp-1s, customers taking a compounded glp-1 reported losing an average of 20.9 pounds or 10.3% of initial.
HIMS Ratings Summary
HIMS Quant Ranking